Home › High Blood Pressure in Pregnancy › NCT06842875
Rhode Island - Statewide Postpartum Hypertension Remote Surveillance
Effect of a Technology-based Collaborative Model on Persistent Hypertension and Preventive Care Attendance Among Postpartum People With Hypertensive Disorders of Pregnancy
Who can join
Ages 18 to 60 · Women
Full eligibility criteria
Inclusion Criteria: * Postpartum patient aged 18 years or more at any birthing hospital in Rhode Island * Diagnosed during pregnancy or after delivery with hypertensive disorder of pregnant * English-, Spanish-, Portuguese-, or Haitian-Creole-speaking * Smartphone ownership Exclusion Criteria: * Prior enrollment in this trial * Prisoners or incarcerated people * Inability or unwillingness to provide informed consent * Inability to communicate with study team, despite an interpreter
About the study
This is a hybrid type 1 non-inferiority implementation effectiveness trial among postpartum patients with hypertension (N=1536) that will test the hypothesis that RI-SPHERES (a technologically enabled collaborative care model) is non-inferior to a standard self-measured blood pressure program in terms of persistent hypertension at six weeks postpartum and preventive care receipt within one year of delivery.
What is being tested
- RI-SPHERES (behavioral)
- Standard self-measured blood pressure program (behavioral)
Sponsor: Women and Infants Hospital of Rhode Island · Participants: 1,536 · Started: Apr 15, 2025
Contact the study team
- Stephanie Nunez, Research Coordinator · Phone: 401-274-1122
Official record on ClinicalTrials.gov — NCT06842875
Locations in the U.S.
| Rhode Island | Newport Hospital, Newport (Not yet recruiting) Women & Infants Hospital of Rhode Island, Providence South County Hospital, Wakefield (Not yet recruiting) Kent Hospital, Warwick Landmark Hospital, Woonsocket |
Conditions
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.